Skip to Main Content

neurology

Here’s the latest research and news on neurology, the medical specialty that deals with the nervous system. Topics include Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, stroke and traumatic brain injury.

Latest

Health Elizabeth Cooney

Serotonin levels are depleted in long Covid patients, study says, pointing to a potential cause for ‘brain fog’

In the Lab Usha Lee McFarling

An effort to diversify genetic research finds new variant for Parkinson’s disease in African populations

Health Bree Iskandar

America’s ERs struggle with timely care for stroke patients

Health Bree Iskandar

How a beautiful symptom of a brutal dementia informs our understanding of creativity

Health Tech Lizzy Lawrence

STAT Plus: For brain-computer interfaces, the commercial hurdles may be bigger than scientific ones

Pharmalot Ed Silverman and Rachel Cohrs

Policy experts call on Medicare to ensure data from Alzheimer’s drug registries is shared publicly

Politics Annalisa Merelli

STAT Plus: Mitch McConnell’s abrupt episode has an important public health takeaway

Health Simar Bajaj

Why nearly half of Americans with Parkinson’s don’t see a neurologist

All Coverage

Pharmalot Ed Silverman

STAT Plus: Bitter infighting leads 15 chapters to break away from leading ALS advocacy group

Pharmalot Ed Silverman

STAT Plus: FDA removes neurologist with financial ties to Eisai and Biogen from Alzheimer’s advisory panel

advertisement

Health Tech Lizzy Lawrence

STAT Plus: Neuralink can now study its brain implant in humans, but it’s still catching up to its peers

Biotech Damian Garde

STAT Plus: Sam Waksal and Jeremy Levin plot ‘the turnaround story of the century’

First Opinion Michael J. Fox

Michael J. Fox: As a Parkinson’s patient, I felt a little left behind by biology’s century — until now

Biotech Adam Feuerstein

STAT Plus: Under protest, FDA to convene advisory panel to review controversial cell therapy for ALS

Adam's Take Adam Feuerstein

STAT Plus: Amylyx’s ALS drug launch starts strong. That could be trouble for the FDA

Pharmalot Ed Silverman

STAT Plus: Veterans Health Administration will cover the newest Alzheimer’s drug

Pharmalot Ed Silverman and Andrew Joseph

STAT Plus: Leading ALS advocacy group roiled by infighting over money and priorities

Health Lauren Gravitz

Scientists are finding increasing evidence for a link between air pollution and neurodegenerative diseases like Alzheimer’s

The Pharmalot View Ed Silverman

STAT Plus: Why a tone-deaf Regeneron executive deserved to be booed over Alzheimer’s drug remarks

Biotech Matthew Herper and Allison DeAngelis

STAT Plus: ‘This is not a cure’: Consensus begins to emerge on new Alzheimer’s drug

First Opinion Earl Smith

Victims of domestic abuse should get the same top-notch concussion care as athletes

Health Tech Mohana Ravindranath and Katie Palmer

STAT Plus: Elon Musk says Neuralink’s brain-machine interface could enter human studies next year

In the Lab Megan Molteni

On the long road to treating Huntington’s genetic stutter, scientists return to overlooked clues

First Opinion Madhav Thambisetty

Anti-amyloid drugs and the mystery of treatment-associated brain shrinkage

Living With Isabella Cueto

Lessons from a thriving physical therapist to a younger self just learning about multiple sclerosis

Health Brian Melley — Associated Press

A jury finds NCAA is not to blame in lawsuit over football player’s death after repeated head trauma

Biotech Allison DeAngelis

STAT Plus: Triplet Therapeutics, biotech company focused on Huntington’s, quietly shuts down

Exclusive Mario Aguilar

STAT Plus: Alzheimer’s clinical trials have a recruitment problem. Telehealth platform Ro thinks it can help

Health Andrew Joseph

STAT Plus: An Alzheimer’s therapy scores winning results, but what could it mean for patients?